ArcticZymes Technologies ASA (B4V.F)

1,9860 -0,0100 (-0,50%) Ab 09:20AM CEST. Markt geöffnet.

ArcticZymes Technologies ASA

Sykehusveien 23
SIVA Innovation Centre PO Box 6463
Tromsø 9294
Norway
47 77 64 89 00
https://arcticzymes.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Marie Ann Roskrow BSc. (Hons), MBBS (Hons), Ph.D.	Executive Chairman	42,57k	N/A	N/A
Mr. Borge Sorvoll	Chief Financial Officer	148,96k	N/A	1975
Dr. Marit Sjo Lorentzen	Vice President of Operations	107,43k	N/A	1968
Mr. Dirk Hahneiser	Vice President of Business Development & Marketing	133,84k	N/A	1968
Mr. Michael Benjamin Akoh	Chief Executive Officer	N/A	N/A	1973
Dr. Jeremy Gillespie	Vice President of Corporate Development	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Corporate Governance

ArcticZymes Technologies ASAs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.